TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1407968

Group type: EXPERIMENTAL
Intervention: Aspirin 650 mg/day
Number of subjects: 3711

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3711

Group type: EXPERIMENTAL
Intervention: Early full scatter photocoagulation
Number of subjects: 3711

Group type: EXPERIMENTAL
Intervention: Early mild scatter photocoagulation
Number of subjects: 3711

Group type: EXPERIMENTAL
Intervention: Deferral of photocoagulation
Number of subjects: 3711

Group type: EXPERIMENTAL
Intervention: Overall (combined endpoint)
Number of subjects: 3711

Group type: EXPERIMENTAL
Intervention: Before vitrectomy
Number of subjects: 3711

Group type: EXPERIMENTAL
Intervention: One year after vitrectomy
Number of subjects: 3711
Study: 2860268

Group type: EXPERIMENTAL
Intervention: Piretanide 12 mg daily (n = 14)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Piretanide 6 mg daily (n = 18)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Beta blockers (pindolol, metipranolol, atenolol, n = 17)
Number of subjects: 49
Study: 31965906

Group type: EXPERIMENTAL
Intervention: Second half-course (SHC) tourniquet application
Number of subjects: 102

Group type: COMPARATOR
Intervention: Full-course (FC) tourniquet application
Number of subjects: 102
Study: 29927750

Group type: EXPERIMENTAL
Intervention: Normocapnic hyperpnea training (group 1)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham maneuvers (group 2)
Number of subjects: 22
Study: 27514766

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid supplementation (1000 mg/d from flaxseed oil)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 25522399

Group type: EXPERIMENTAL
Intervention: Lithium treatment (6 weeks)
Number of subjects: 19
Study: 22857780

Group type: EXPERIMENTAL
Intervention: Avanafil 100 mg
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Avanafil 200 mg
Number of subjects: 390

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 390
Study: 19855976

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate only (25 mg, four times/week)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Tamsulosin only (0.4 mg once daily)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination of sildenafil citrate and tamsulosin
Number of subjects: 60
Study: 18721577

Group type: EXPERIMENTAL
Intervention: iNO + Mil (inhalation of nitric oxide plus milrinone)
Number of subjects: 46

Group type: COMPARATOR
Intervention: iNO (inhalation of nitric oxide)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Mil (milrinone)
Number of subjects: 46
Study: 15985065

Group type: EXPERIMENTAL
Intervention: Learning group (5-year-old children and adults)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Other groups (not learning the category distinction)
Number of subjects: 2
Study: 12464165

Group type: EXPERIMENTAL
Intervention: Oral immunotherapy with Alternaria extract (mean accumulated dose: 280,000 PNU)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Oral immunotherapy with Alternaria extract
Number of subjects: 39

Group type: COMPARATOR
Intervention: Symptomatic treatment (control group)
Number of subjects: 39
Study: 10597050

Group type: EXPERIMENTAL
Intervention: Progressive resistance training
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Progressive resistance training (Charcot‐Marie‐Tooth group)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Progressive resistance training (after 24 weeks)
Number of subjects: 62
Study: 8739163

Group type: EXPERIMENTAL
Intervention: Root surfaces smoothed after plaque and calculus removal using Gracey curettes; evaluated at 3 and 6 months post-surgery
Number of subjects: 13

Group type: COMPARATOR
Intervention: Root surfaces roughened using a coarse diamond stone after traditional root planing; evaluated at 3 and 6 months post-surgery
Number of subjects: 13
Study: 1868680

Group type: EXPERIMENTAL
Intervention: Low-dose phenobarbital incorporated into methadone medication
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Laboratory measurements of phenobarbital and methadone
Number of subjects: 20
Study: 7092752

Group type: EXPERIMENTAL
Intervention: Autogenic-feedback training (Group I)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham training in an alternative cognitive task (Group II)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No treatment (Group III)
Number of subjects: 18
Study: 31192911

Group type: EXPERIMENTAL
Intervention: Morning surgery (Group A)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Afternoon surgery (Group B)
Number of subjects: 44
Study: 28138179

Group type: EXPERIMENTAL
Intervention: Thiopental 3 mg/kg intravenously followed by an additional dose of 1 mg/kg to achieve Ramsay sedation score of 4
Number of subjects: 120

Group type: COMPARATOR
Intervention: Ketofol (1:1 mixture of ketamine 10 mg/mL and propofol 10 mg/mL) at a dose of 0.5 mg/kg at 1 minute intervals to achieve Ramsay sedation score of 4
Number of subjects: 120
Study: 26230151

Group type: EXPERIMENTAL
Intervention: Primed during the list study phase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Primed during the memory test phase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Primed during both phases
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unprimed problems
Number of subjects: 0
Study: 25349008

Group type: EXPERIMENTAL
Intervention: Morphine (0.5 mg/kg orally)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Ibuprofen (10 mg/kg)
Number of subjects: 134
Study: 21797891

Group type: EXPERIMENTAL
Intervention: Intravenous alcohol infusion (50 mg%) for 3 hours
Number of subjects: 48

Group type: COMPARATOR
Intervention: Saline infusion for 3 hours
Number of subjects: 48
Study: 19020525

Group type: EXPERIMENTAL
Intervention: Hypothermia treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 0
Study: 17550348

Group type: EXPERIMENTAL
Intervention: HUT with occlusion (pressure cuff at 250 mmHg)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: HUT without occlusion
Number of subjects: 22
Study: 15827099

Group type: EXPERIMENTAL
Intervention: octreotide-LAR (10 mg, n = 10 subjects)
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo (n = 10 subjects)
Number of subjects: 20
Study: 12072674

Group type: EXPERIMENTAL
Intervention: Intravenous erythromycin (250 mg/6 hrs)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (intravenous 5% dextrose, 50 mL/6 hrs)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 9576385

Group type: EXPERIMENTAL
Intervention: PCR assay for Hib DNA in blood culture supernatants
Number of subjects: 1575

Group type: COMPARATOR
Intervention: Conventional culture techniques
Number of subjects: 1575
Study: 7827545

Group type: EXPERIMENTAL
Intervention: Quinine (as quinine sulphate)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 1325513

Group type: EXPERIMENTAL
Intervention: Spirapril 12.5 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Spirapril 25 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Spirapril (both doses)
Number of subjects: 16
Study: 6594021

Group type: EXPERIMENTAL
Intervention: Duraphat
Number of subjects: 381

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 381
Study: 30556959

Group type: EXPERIMENTAL
Intervention: Miridesap 10 mg IV infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Miridesap 20 mg IV infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Miridesap 40 mg IV infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Miridesap 20 mg/h IV infusion (15-hour duration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28926864

Group type: EXPERIMENTAL
Intervention: Mitomycin C (Synergo ®)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conductive Mitomycin C therapy (Combat ® and Unithermia ® devices)
Number of subjects: 0
Study: 26708124

Group type: EXPERIMENTAL
Intervention: Fluoxetine (8 to 15 mg, titrated to weight)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 12
Study: 24644106

Group type: EXPERIMENTAL
Intervention: Duloxetine 30-120 mg once daily
Number of subjects: 291

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 291
Study: 22305835

Group type: EXPERIMENTAL
Intervention: Cangrelor (30 μg/Kg bolus plus 4 μg/Kg/min infusion)
Number of subjects: 13049

Group type: COMPARATOR
Intervention: Clopidogrel (600 mg loading dose)
Number of subjects: 13049
Study: 20300081

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 213

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 213
Study: 18052563

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 345
Study: 16116318

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus strain GG (LGG)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 12408205

Group type: EXPERIMENTAL
Intervention: Innovative behavioral intervention based on net-present value economic theory
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard risk-factor approach in control group
Number of subjects: 0
Study: 9237705

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (125 mg, 250 mg, 500 mg daily for 14 days)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (125 mg daily)
Number of subjects: 36
Study: 8216067

Group type: EXPERIMENTAL
Intervention: Polyglyconate suture (Maxon)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Other currently available sutures
Number of subjects: 56
Study: 2448657

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (3 g/m2 iv weekly with leukovorin rescue)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Low-dose methotrexate (30 mg/m2 orally weekly without rescue)
Number of subjects: 166

Group type: COMPARATOR
Intervention: CAVP therapy
Number of subjects: 166

Group type: COMPARATOR
Intervention: Patients with 'B' symptoms
Number of subjects: 166
Study: 30354411

Group type: EXPERIMENTAL
Intervention: Catheter Ablation (CA)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Surgical MIPI
Number of subjects: 52
Study: 27567756

Group type: EXPERIMENTAL
Intervention: 300 mg of extended-release theophylline
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 24925330

Group type: EXPERIMENTAL
Intervention: Pacing post-conditioning (PPC) plus percutaneous coronary intervention (PCI)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 60
Study: 22379743

Group type: EXPERIMENTAL
Intervention: Dexpanthenol nasal spray
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal saline nasal spray
Number of subjects: 50
Study: 20150523

Group type: EXPERIMENTAL
Intervention: Gemfibrozil (600 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Rosuvastatin (20 mg)
Number of subjects: 8
Study: 18191847

Group type: EXPERIMENTAL
Intervention: Progesterone (P) only as luteal support (200 mg bid starting the following night after oocyte retrieval)
Number of subjects: 176

Group type: COMPARATOR
Intervention: E(2) and P combined (E(2) patches 100 microg/day twice per week starting on the day of embryo transfer with P)
Number of subjects: 176
Study: 16157525

Group type: EXPERIMENTAL
Intervention: Dipyridamole (0.74 mg/kg of body weight) used for coronary flow reserve assessment
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Number of risk factors (0-3)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Degree of coronary artery stenosis
Number of subjects: 48
Study: 14503903

Group type: COMPARATOR
Intervention: Sling treatment for shoulder dislocation
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: External rotation treatment (splint or pillow)
Number of subjects: 3
Study: 10825403

Group type: EXPERIMENTAL
Intervention: Computer-assisted venous occlusion plethysmography
Number of subjects: 215

Group type: COMPARATOR
Intervention: Standard radiology
Number of subjects: 215
Study: 8863556

Group type: EXPERIMENTAL
Intervention: 20 mg fluoxetine daily for 1 week and 40 mg daily afterward (group 1)
Number of subjects: 17

Group type: COMPARATOR
Intervention: 1 capsule placebo daily for 1 week and 2 capsules daily afterward (group 2)
Number of subjects: 17
Study: 1407240

Group type: EXPERIMENTAL
Intervention: 1500 mg/day calcium supplement
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 3903158

Group type: EXPERIMENTAL
Intervention: D-penicillamine
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 31061380

Group type: EXPERIMENTAL
Intervention: Post-transplantation care in the first year
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Post-transplantation care after the first year
Number of subjects: 306
Study: 28929567

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 4004

Group type: COMPARATOR
Intervention: Control (no BCG vaccination)
Number of subjects: 4004

Group type: EXPERIMENTAL
Intervention: BCG vaccination in children with atopic predisposition
Number of subjects: 4004

Group type: EXPERIMENTAL
Intervention: BCG vaccination in children without atopic predisposition
Number of subjects: 4004
Study: 26721340

Group type: EXPERIMENTAL
Intervention: Regular-flavored dentifrice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Specially-flavored dentifrice
Number of subjects: 0
Study: 24050647

Group type: EXPERIMENTAL
Intervention: Muscle Shortening Manoeuvre (MSM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional physiotherapeutic technique (scapulothoracic gliding)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Simple traction (added mass applied without fast accelerations)
Number of subjects: 60
Study: 22538275

Group type: EXPERIMENTAL
Intervention: Ultracision knife
Number of subjects: 5

Group type: COMPARATOR
Intervention: Conventional Metzenbaum-type scissors and surgical knife
Number of subjects: 5
Study: 20186436

Group type: EXPERIMENTAL
Intervention: Remifentanil 0.1 microg kg(‐1) min(‐1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Remifentanil 0.2 microg kg(‐1) min(‐1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Remifentanil 0.5 microg kg(‐1) min(‐1)
Number of subjects: 60
Study: 18556898

Group type: EXPERIMENTAL
Intervention: Sensory integration therapy program
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 30
Study: 16013898

Group type: EXPERIMENTAL
Intervention: Modafinil up to 200 mg a day (N = 13)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (N = 11)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Modafinil (N = 10)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (N = 10)
Number of subjects: 24
Study: 11889331

Group type: EXPERIMENTAL
Intervention: Trials reporting mortality as the primary outcome
Number of subjects: 74

Group type: COMPARATOR
Intervention: Trials focusing on surrogate outcome measures
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Mortality outcome trials
Number of subjects: 74

Group type: COMPARATOR
Intervention: Surrogate outcome trials
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Overall trial methodology
Number of subjects: 74
Study: 10431093

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendicectomy (LA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open appendicectomy (OA)
Number of subjects: 0
Study: 8640151

Group type: EXPERIMENTAL
Intervention: Ribomunyl
Number of subjects: 14
Study: 2125658

Group type: EXPERIMENTAL
Intervention: Bismuth salicylate
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 356235

Group type: EXPERIMENTAL
Intervention: Proquazone
Number of subjects: 18

Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 18
Study: 31184792

Group type: EXPERIMENTAL
Intervention: Cognitive education in the format of mind maps
Number of subjects: 136

Group type: COMPARATOR
Intervention: Conventional education
Number of subjects: 136
Study: 27993433

Group type: EXPERIMENTAL
Intervention: Regular care plus self-management intervention (education, motivational interviewing, coaching, self-monitoring of BP and sodium)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Regular care plus self-management intervention
Number of subjects: 138

Group type: COMPARATOR
Intervention: Regular care only (Control)
Number of subjects: 138
Study: 25842396

Group type: EXPERIMENTAL
Intervention: Atomized lidocaine administered via intranasal mucosal delivery device
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atomized lidocaine
Number of subjects: 0
Study: 23973186

Group type: EXPERIMENTAL
Intervention: Abiraterone acetate
Number of subjects: 1195

Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 1195
Study: 20497775

Group type: EXPERIMENTAL
Intervention: 10-g dose of oligofructose
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 5-g dose of oligofructose
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 10-g dose of native inulin
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 5-g dose of native inulin
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 18565489

Group type: EXPERIMENTAL
Intervention: Optimal analgesia
Number of subjects: 1756

Group type: COMPARATOR
Intervention: Suboptimal analgesia
Number of subjects: 1756

Group type: EXPERIMENTAL
Intervention: Increasing levels of pain
Number of subjects: 1756
Study: 16176615

Group type: EXPERIMENTAL
Intervention: EGCG-caffeine mixtures (200 mg caffeine and variable doses of EGCG: 90, 200, 300, or 400 mg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: EGCG-caffeine mixtures
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 12949316

Group type: EXPERIMENTAL
Intervention: NFV 30 mg/kg TID
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: NFV 55 mg/kg BID
Number of subjects: 51
Study: 10755203

Group type: EXPERIMENTAL
Intervention: Celiprolol (200‐400 mg daily)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Control group (unchanged therapy)
Number of subjects: 169
Study: 9063232

Group type: EXPERIMENTAL
Intervention: Glass-ionomer cement
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Resin composite with a dentinal bonding agent
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Laminate (sandwich) restoration
Number of subjects: 159
Study: 2066840

Group type: EXPERIMENTAL
Intervention: Formula with 2.2 gm protein/100 kcal
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Formula with 2.7 gm protein/100 kcal
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Formula with 3.2 gm protein/100 kcal
Number of subjects: 3
Study: 6348986

Group type: EXPERIMENTAL
Intervention: 45% BCAA solution
Number of subjects: 8

Group type: COMPARATOR
Intervention: 25% BCAA solution
Number of subjects: 8
Study: 29467087

Group type: EXPERIMENTAL
Intervention: New disposable device for ultrasound-guided internal jugular vein cannulation
Number of subjects: 88

Group type: COMPARATOR
Intervention: Standard ultrasound-guided approach without the device
Number of subjects: 88
Study: 27706046

Group type: EXPERIMENTAL
Intervention: Internet-based exercise training (e-training) for pwMS, 1×/week aerobic and 2×/week strength training for six months
Number of subjects: 126

Group type: COMPARATOR
Intervention: Internet-based exercise training (e-training) for pwMS
Number of subjects: 126
Study: 24656700

Group type: EXPERIMENTAL
Intervention: Diane-35
Number of subjects: 76

Group type: COMPARATOR
Intervention: MPA
Number of subjects: 76
Study: 23647761

Group type: EXPERIMENTAL
Intervention: SEMS followed by brachytherapy, 8 Gy×3
Number of subjects: 41

Group type: COMPARATOR
Intervention: brachytherapy alone, 8 Gy×3
Number of subjects: 41
Study: 21655317

Group type: EXPERIMENTAL
Intervention: Subsidized artemether-lumefantrine (AL) provided through retail outlets
Number of subjects: 2749

Group type: COMPARATOR
Intervention: Control group (no subsidized AL)
Number of subjects: 2749

Group type: COMPARATOR
Intervention: Comparison between intervention and control
Number of subjects: 2749

Group type: COMPARATOR
Intervention: Caregivers seeking treatment for child's fever
Number of subjects: 2749

Group type: COMPARATOR
Intervention: Child's adherence to AL
Number of subjects: 2749
Study: 19099786

Group type: EXPERIMENTAL
Intervention: Hydrochloride valacyclovir
Number of subjects: 260

Group type: COMPARATOR
Intervention: Ribavirin
Number of subjects: 260
Study: 16752333

Group type: COMPARATOR
Intervention: OTW in-stent occlusive (3 x 3 min.) BMSC delivery
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Cell infusion via a perfusion catheter with multiple side holes (SH-PC)
Number of subjects: 11
Study: 12456508

Group type: EXPERIMENTAL
Intervention: PCT test pooled, leukoreduced platelet components (311 transfusions)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Conventional reference pooled, leukoreduced platelet components (256 transfusions)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: PCT test pooled, leukoreduced platelet components
Number of subjects: 103

Group type: COMPARATOR
Intervention: Conventional reference pooled, leukoreduced platelet components
Number of subjects: 103
Study: 10983907

Group type: EXPERIMENTAL
Intervention: Comprehensive Geriatric Assessment (CGA) implemented by a Mobile Geriatric Assessment Team (MGAT) for 3 months
Number of subjects: 182

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Comprehensive Geriatric Assessment (CGA)
Number of subjects: 182
Study: 8852913

Group type: EXPERIMENTAL
Intervention: Education group (E) - received instructions about protective behaviors and risky behaviors to avoid, provided with disposable diapers, liquid soap, and latex gloves.
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Adherence and education group (A) - received social reinforcement for adherence and problem solving in addition to education.
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (C) - received no intervention.
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Pregnant women - received an intervention equivalent to that of the education group.
Number of subjects: 42
Study: 1518701

Group type: EXPERIMENTAL
Intervention: IVF children
Number of subjects: 116

Group type: COMPARATOR
Intervention: Twins and triplets (IVF and controls)
Number of subjects: 116